Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home

COVID-19 has affected millions of patients, caregivers, and clinicians around the world. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads via droplets and close contact from person to person, and there has been an increased concern regarding aerosol drug delivery due to the poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Ari, Arzu, Blain, Karen, Soubra, Said, Hanania, Nicola A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487292/
https://www.ncbi.nlm.nih.gov/pubmed/34611397
http://dx.doi.org/10.2147/COPD.S332021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487292/
https://www.ncbi.nlm.nih.gov/pubmed/34611397
http://dx.doi.org/10.2147/COPD.S332021

Ejemplares similares